The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Rogaratinib treatment of patients with advanced urothelial carcinomas prescreened for tumor FGFR mRNA expression.
 
Markus Joerger
No Relationships to Disclose
 
Philippe Cassier
No Relationships to Disclose
 
Nicolas Penel
No Relationships to Disclose
 
Richard Cathomas
No Relationships to Disclose
 
Heike Richly
No Relationships to Disclose
 
Martin Schostak
Honoraria - Bayer; Sanofi
Consulting or Advisory Role - Bayer; Janssen; Sanofi
Research Funding - Bayer; Bristol-Myers Squibb; Roche
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Roche; Sanofi
 
Andreas Janitzky
No Relationships to Disclose
 
Martin Wermke
No Relationships to Disclose
 
Lucia Nogova
Honoraria - Celgene; Novartis; Pfizer; Pfizer
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Novartis; Roche
Research Funding - Bristol-Myers Squibb (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Celgene; Novartis; Pfizer
 
David Wai-Meng Tai
No Relationships to Disclose
 
Cyrus Sayehli
No Relationships to Disclose
 
Carsten Grüllich
No Relationships to Disclose
 
Enrique Grande
No Relationships to Disclose
 
Alejandra Navarro
No Relationships to Disclose
 
Se Hoon Park
No Relationships to Disclose
 
Silke Gillessen
Consulting or Advisory Role - Active Biotech (Inst); Active Biotech (Inst); Advanced Accelerator Applications (Inst); Advanced Accelerator Applications (Inst); Astellas Pharma (Inst); Bayer; Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); CureVac (Inst); Curevac (Inst); Dendreon; Ferring (Inst); Ferring (Inst); Innocrin Pharma (Inst); Janssen (Inst); Janssen-Cilag; MaxiVax ; Millennium; Novartis (Inst); Orion; Roche (Inst); Sanofi; Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Method for biomarker (WO 3752009138392 A1)
Travel, Accommodations, Expenses - Diverse Companies
Other Relationship - ESSA; Nektar; ProteoMediX
 
Hendrik Nogai
Employment - Bayer
 
Sebastian Bender
Employment - Bayer
 
Peter Ellinghaus
Employment - Bayer
 
Martin H. Schuler
Employment - – Universität Duisburg-Essen, Universitätsklinikum Essen, Ruhrlandklinik
Honoraria - Abbvie; Alexion Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; MSD; Novartis
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; Novartis; Roche
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst)